Development and validation of RP-HPLC method for simultaneous estimation of Ertugliflozin and Sitagliptin in bulk drug and tablet dosage form

S. D. Mankar; Priyanka Sagar; Sanjay Bhawar; Suhas Siddheshwar; Santosh Dighe

doi:10.52756/ijerr.2023.v32.025

Authors

S. D. Mankar Department of Quality Assurance Technique, Pravara Rural College of Pharmacy, Pravaranagar, Rahta, Ahmednagar- 413737, India https://orcid.org/0000-0003-3991-9412
Priyanka Sagar Department of Quality Assurance Technique, Pravara Rural College of Pharmacy, Pravaranagar, Rahta, Ahmednagar- 413737, India
Sanjay Bhawar Department of Quality Assurance Technique, Pravara Rural College of Pharmacy, Pravaranagar, Rahta, Ahmednagar- 413737, India https://orcid.org/0000-0002-5345-0799
Suhas Siddheshwar Department of Quality Assurance Technique, Pravara Rural College of Pharmacy, Pravaranagar, Rahta, Ahmednagar- 413737, India https://orcid.org/0000-0002-7944-9470
Santosh Dighe Department of Quality Assurance Technique, Pravara Rural College of Pharmacy, Pravaranagar, Rahta, Ahmednagar- 413737, India https://orcid.org/0000-0003-3260-2981

DOI:

https://doi.org/10.52756/ijerr.2023.v32.025

Keywords:

Ertugliflozin, RP-HPLC, Sitagliptin, Tablet

Abstract

To treat type 2 diabetes, in a combined tablet dosage form the ertugliflozin and sitagliptin were administered. Considering the less complication and readily availability of HPLC, the main objective of present study was to develop a new, precise, accurate, linear, robust, and economical RP-HPLC method for the simultaneous estimation of ertugliflozin and sitagliptin in tablet dosage form. Effective chromatographic separation of Ertugliflozin and Sitagliptin was achieved on Kromasil C18 (5 µm 250 mm X 4.6 mm) and the mobile phase containing Methanol and 0.1% OPA in water isocratic elution mode at a flow rate of 1.0mL/min. with column temperature at 30 °C and the injection volume was 20 µL at column temperature at 30°C. At an isosbestic wavelength of 212 nm, ertugliflozin and sitagliptin were found to have retention times of 5.30 min. and 2.05 min., respectively. The method was proven to be precise (%RSD 2%), accurate (>90%), and specific for the simultaneous measurement of both drugs in tablets. As a result, the suggested method with excellent specificity, accuracy, precision, linearity and robustness as well as economical was useful for the regular quality control analysis of ertugliflozin and sitagliptin tablets.

References

China, B.D., Madhusudhana, C.C., & Mastanamma, S. (2019). A new stress indicating RP-HPLC method development and validation for the simultaneous estimation of ertugliflozin and metformin in bulk and its tablet dosage form. Indian Drugs, 56(2), 39–46. https://doi.org/10.53879/id.56.02.11529

Davis, J. A., Singh, S., Sethi, S., Roy, S., Mittra, S., Rayasam, G., Bansal, V., Sattigeri, J., & Ray, A. (2010). Nature of action of Sitagliptin, the dipeptidyl peptidase-IV inhibitor in diabetic animals. Indian Journal of Pharmacology, 42(4), 229–233. https://doi.org/10.4103/0253-7613.68425

Fediuk D.J., Nucci, G., & Dawra, V.K. (2020). Overview of the Clinical Pharmacology of Ertugliflozin, a Novel Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor. Clin. Pharmacokinet, 59(8), 949–965. https://doi.org/10.1007/s40262-020-00875-1

Rajeswari, A., Saritha, N., & Devanna, N. (2022). Validated RP-HPLC Method Development for Estimation of Ertugliflozin and Sitagliptin in Bulk and Dosage Forms. Journal of Pharmaceutical Research International, 34(20b), 22-26. https://doi.org/10.9734/jpri/2022/v34i20B35829

Raju, M., Hanzal, F., Hafsa, S., & Chaitanya, S. K. (2021). Development and Validation of An Analytical Method for The Simultaneous Estimation of Ertugliflozin and Sitagliptin in Bulk and Pharmaceutical Dosage Form. J. Global Trends Pharm. Sci., 12(2), 9378–9386.

Venkateswara Rao, A Lakshmana Rao S Prasad. (2018). A new stability indicating Simultaneous Estimation of Ertugliflozin and Sitagliptin in Bulk and Pharmaceutical Dosage Form, Its Validation Parameters as Per Ich Guidelines. Indo American Journal of Pharmaceutical Sciences, 05(04), 2616–27. http://doi.org/10.5281/zenodo.1220228

Vilas, B. G., Kharat, N.R., & Dighe, N. (2022). Development and Validation of RP-HPLC Method for Simultaneous Estimation of Ertugliflozin and Sitagliptin in Tablet Formulation. Journal of Education: Rabindra Bharati University, 23(1), 614-626.